Rexulti 2 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FR1QG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,498
Award facts
- Contract value 100% obligated
- $10,497.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Rexulti 2 mg tablets (30-count packages) valued at $10,497.83. This firm fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, represents a competitively awarded, non-set-aside procurement. The contract will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of October 29, 2025.
This delivery order falls under AmerisourceBergen Drug Corp's existing $999,999,999 IDC with DLA Troop Support Medical (SPE2DX), which operates through December 2026 and serves as the primary pharmaceutical supply vehicle for military healthcare systems. The award reflects AmerisourceBergen's established role as a critical vendor in the federal medical supply chain, providing brand-name and generic medications across multiple therapeutic domains to support Defense Health Agency and other government healthcare operations. Rexulti is an atypical antipsychotic medication used in psychiatric treatment, consistent with the company's portfolio of specialized pharmaceutical products delivered through competitively awarded contracts.
Quick answers
Who was awarded contract SPE2DB26FR1QG?
SPE2DB26FR1QG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FR1QG worth?
The government has obligated $10,498 on SPE2DB26FR1QG.
Is contract SPE2DB26FR1QG an order under another contract?
Yes. SPE2DB26FR1QG is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB26FR1QG competed?
The extent of competition for SPE2DB26FR1QG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award